Guanine

Guanine

SCHEMBL2636587

Nc1cc[nH]c(=O)n1.Nc1nc2nc[nH]c2c(=O)[nH]1.Nc1ncnc2nc[nH]c12.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PNP P00491 2/20 0.51
PI4KA P42356 4/20 0.43
PI4K2B Q8TCG2 4/20 0.43
PI4K2A Q9BTU6 4/20 0.43
PI4KB Q9UBF8 4/20 0.43
LMNA P02545 1/20 0.43
DRD3 P35462 1/20 0.43
XDH P47989 1/20 0.43
LRRK2 Q5S007 1/20 0.43
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GDA Q9Y2T3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL37966 0.93 PNP (0.59) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL4577523 0.93 PNP (0.59) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL15718981 0.92 PNP (0.43) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL5579240 0.92 PNP (0.60) PNPKDM4EMEN1ALDH1A1MAPT
Guanine SCHEMBL9468227 0.91 PNP (0.43) PNPPI4KAPI4K2BPI4K2API4KB
2,6-Diaminopurine SCHEMBL23292805 0.88 PNP (0.53) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL5097009 0.87 PNP (0.47) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL9468295 0.86 PNP (0.46) PNPPI4KAPI4K2BPI4K2API4KB
Guanine SCHEMBL17542296 0.85 PNP (0.49) PNPPI4KAPI4K2BPI4K2API4KB
Adenine SCHEMBL6227732 0.85 PI4KA (0.41) PNPPI4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458474-A1 COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF Modernatx, Inc. (US) 2019-03-27 EP disclosed
EP-3458092-A1 MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER Modernatx, Inc. (US) 2019-03-27 EP disclosed
EP-3458083-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF Modernatx, Inc. (US) 2019-03-27 EP disclosed
EP-3394093-A1 METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES Modernatx, Inc. (US) 2018-10-31 EP disclosed
WO-2017201352-A1 MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER MODERNATX, INC. (US) 2017-11-23 WO disclosed
WO-2017201325-A1 COMBINATIONS OF MRNAS ENCODING IMMUNE MODULATING POLYPEPTIDES AND USES THEREOF MODERNATX, INC. (US) 2017-11-23 WO disclosed
WO-2017201350-A1 POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF MODERNATX, INC. (US) 2017-11-23 WO disclosed
WO-2017112943-A1 METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES MODERNATX, INC. (US) 2017-06-29 WO disclosed
EP-3157573-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP disclosed
EP-3157572-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF Moderna Therapeutics, Inc. (US) 2017-04-26 EP disclosed
WO-2015196128-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
WO-2015196130-A2 ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF MODERNA THERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
WO-2014078652-A1 HEAVY ATOM LABELED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACID POLYMERS, AND USES THEREOF ZS GENETICS, INC. (US) 2014-05-22 WO disclosed
WO-2012075114-A2 NUCLEIC ACID-POLYMER CONJUGATES AND USES THEREOF ABLITECH, INC. (US) 2012-06-07 WO disclosed
EP-2437789-A1 BIOMOLECULE-POLYMER CONJUGATES AND METHODS OF MAKING SAME Ablitech, Inc. (US) 2012-04-11 EP disclosed
WO-2010141507-A1 BIOMOLECULE-POLYMER CONJUGATES AND METHODS OF MAKING SAME ABLITECH, INC. (US) 2010-12-09 WO disclosed